BIG PHARMA WATCH: LIST PRICES ON TOP 25 MEDICARE PART D DRUGS MORE THAN TRIPLED SINCE COMING TO MARKET
Aug 17, 2023
AARP Analysis Finds Prices for Best-Selling Medicare Part D Drugs Rose 226… Read More
© 2026 CSRXP- All Rights Reserved
Big Pharma Watch
BIG PHARMA WATCH: COLOSSAL $81.9 BILLION IN 2022 EARNINGS FOR LARGEST DRUG MAKERS FUELED HUGE PROFITS
Jul 25, 2023
Top Five Drug Makers By U.S. Market Cap Plowed Soaring Earnings Into Stock… Read More
BIG PHARMA WATCH: DRUG MAKER’S PRODUCT-HOPPING SCHEME BLOCKED ACCESS TO SAFER HIV MEDICATIONS TO JUICE PROFITS
Jul 24, 2023
The New York Times Exposes How Gilead Devised Egregious Patent Strategy to… Read More
BIG PHARMA WATCH: HHS SECRETARY WARNS COVID-19 VACCINE MAKERS OVER “PRICE-GOUGING BEHAVIOR”
Jul 14, 2023
Becerra Encourages Manufacturers to Set “Reasonable” Prices on Upcoming… Read More
BIG PHARMA WATCH: BIG PHARMA ALREADY INCREASING PRICES ON NEW RSV VACCINES TO BOOST PROFITS
Jul 13, 2023
Manufacturers Increasing Prices in Lockstep to Raise Prices Across New Drug… Read More
BIG PHARMA WATCH: BIG PHARMA EXPOSED FOR CONTINUING TO HIKE PRICES FASTER THAN RATE OF INFLATION
Jun 16, 2023
HHS & CMS Announce New Penalties That Help Hold Brand Name Drug Companies… Read More
BIG PHARMA WATCH: BIG PHARMA SPENT $8.1 BILLION ON ADS PUSHING HIGH-PRICED BRAND NAME PRESCRIPTION DRUGS IN 2022
May 1, 2023
Big Pharma Spending Binge Underscores Bipartisan Support for List Price… Read More
BIG PHARMA WATCH: NEW REPORT HIGHLIGHTS BIG PHARMA’S RAPIDLY RISING LAUNCH PRICES
Mar 10, 2023
Wall Street Journal Analysis Finds Median Monthly Price for Newly Approved… Read More
BIG PHARMA WATCH: NYT REPORT DOCUMENTS NARCOLEPSY DRUG MAKER’S EGREGIOUS EXPLOITATION OF PATENT SYSTEM
Feb 28, 2023
Anti-Competitive Strategy Around Brand Name Narcolepsy Medications Blocked… Read More
BIG PHARMA WATCH: BIG PHARMA SET RECORD FOR OUT-OF-CONTROL LAUNCH PRICES IN 2022 AS MEDIAN PRICE OF NEW TREATMENTS SURGED PAST $220,000
Jan 6, 2023
Brand Name Drug Companies Setting Egregious Prices on New Products Not… Read More
BIG PHARMA WATCH: U.S. HOUSE REPORT DETAILS “UNJUSTIFIABLY HIGH PRICE” OF UNPROVEN ALZHEIMER’S DRUG ADUHELM
Jan 3, 2023
Congressional Probe Concludes Biogen Set Egregious Price Tag on Aduhelm to… Read More
BIG PHARMA WATCH: UNJUSTIFIED PRICE HIKES ON JUST SEVEN DRUGS COST U.S. $805 MILLION IN 2021
Dec 7, 2022
Brand Name Drug Companies Continue Raising Prices on Blockbuster Products With… Read More